insights_auto
Why is INO up 2.92%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.76
arrow_upward
+2.92%(+0.050) 1D
$1.76
arrow_upward
+0.20% (+0.0036)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.72
High
$1.78
Low
$1.62
Mkt. cap
329.66M
Avg. vol.
20.44M
Volume
7.69M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.72
High
$1.78
Low
$1.62
Mkt. cap
329.66M
Avg. vol.
20.44M
Volume
7.69M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
News Corp
·
23 minutes ago
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Yahoo Finance
·
2 days ago
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
The Business Journals
·
3 days ago
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com